We previously showed that NUDT21-spanning copy-number variations (CNVs) are associated 30 with intellectual disability (Gennarino et al., 2015). However, the patients' CNVs also included 31 other genes. To determine if reduced NUDT21 function alone can cause disease, we generated 32 Nudt21 +/mice to mimic the human state of decreased expression. We found that although these 33 mice have 50% reduced Nudt21 mRNA, they only have 30% less of its cognate protein, CFIm25. 34
INTRODUCTION 43
The brain is acutely sensitive to the dose of numerous proteins, such that even small 44 perturbations in their levels can cause neurological disease. Proteins that affect the expression of 45 NUDT21 if loss of function were not pathogenic, but instead there are only 15 missense and zero 84 loss-of-function variants, suggesting that NUDT21 loss of function is incompatible with health 85 (Lek et al., 2016) . Given this evidence, we hypothesized that NUDT21 variants can cause 86 neurological disease through APA misregulation of MECP2 and other dose-sensitive genes in 87 neurons. 88
Combining results from our previous work with data from the Decipher database, we 89 have identified nine individuals with NUDT21-spanning duplications that have intellectual 90 disability, and two patients with deletions that have both intellectual disability and seizures (Firth 91 et al., 2009; Gennarino et al., 2015) . However, the duplication patients also have three other 92 genes common to their copy-number variations (CNVs) and the deletion patients have nearly 20 93 common genes (Gennarino et al., 2015) . CNVs of these other genes could be causing their 94 symptoms. Therefore, it is important to determine if NUDT21 loss of function alone is sufficient 95 to cause disease. Identifying the disease-causing genes within CNVs facilitates more accurate 96 5 diagnosis and prognosis, and allows for targeted therapy development. To that end, we generated 97 Nudt21 +/mice to model the reduced CFIm25 expression observed in humans and assessed for 98 phenotypes similar to the symptoms seen in the deletion patients. We found that Nudt21 99 heterozygosity causes a 50% loss of wild-type Nudt21 mRNA as expected, but only a 30% 100 reduction of its cognate protein, CFIm25. Consistent with what we observed in the deletion 101 patients, we found that Nudt21 loss of function is sufficient to cause learning deficits in mice 102 using a variety of behavioral assays. Further, to see how NUDT21 loss might lead to disease, we 103 analyzed NUDT21-depleted human neurons for aberrant alternative polyadenylation with 3' end 104 sequencing and for protein level aberrations with quantitative mass spectrometry. These 105 approaches showed that a 30% reduction of CFIm25 in human neurons induces widespread 106 abnormal alternative polyadenylation and protein levels, including for dozens of dose-sensitive, 107 disease-associated genes. Altogether, these results provide important in vivo and human-specific 108 evidence that reduced NUDT21 expression can lead to intellectual disability. 109 110
RESULTS 111
Nudt21 heterozygotes have 50% less Nudt21 mRNA in their brain, but only 30% reduced 112 CFIm25 protein. Nudt21 expression has not been well explored within organisms, particularly 113 in the brain. Thus, we first sought to confirm that mice express Nudt21 in the brain, and found 114 that we could readily detect CFIm25 in neuronal nuclei in regions important for learning and 115 memory-the cortex and hippocampus (Figure 1A) . We then generated Nudt21 knockout mice 116 by excising exons two and three, which removes the RNA-binding domain of CFIm25 and 117 induces a frame shift mutation leading to nonsense-mediated decay of the transcript (Figure 1B) 118 (Yang et al., 2011) . We crossed the Nudt21 +/mice with each other and observed that of the 32 119 6 pups born, there were no homozygous null offspring, indicating that Nudt21 is essential for life 120 (Figure 1C) . Unexpectedly, while the heterozygous mice have the anticipated 50% reduction in 121 wildtype Nudt21 mRNA in whole-brain extracts, there was only ~30% reduction in CFIm25 122 protein (Figures 1D & E) . These results demonstrate the successful knockout of one Nudt21 123 copy and reveal a partial post-transcriptional compensation of CFIm25 protein levels. Finally, we 124 found that the Nudt21 +/mice had a normal life span, but consistently weighed ~10% less than 125 their wild-type littermates, indicating that Nudt21 heterozygosity might cause some 126 abnormalities (Figure 1-figure supplement 1) . 127 128 Partial loss of CFIm25 causes learning deficits. To determine if Nudt21 heterozygosity affects 129 cognitive function, we compared Nud21 +/mice and their wild-type littermates in several 130 neurobehavioral assays starting at 30 weeks of age. We focused on learning and memory assays 131 because intellectual disability is the most pronounced and consistent symptom seen in patients 132 with NUDT21-spanning CNVs (Gennarino et al., 2015) . We started with the conditioned fear 133 test, which assesses the mice's ability to learn to associate an aversive event with a sensory 134 context. In this test, we initially train the mice by exposing them to two tone-shock pairings in a 135 novel chamber. Healthy mice will freeze as a behavioral expression of fear when they hear the 136 tone for the second time. The following day, we return the mice to the same chamber, where 137 healthy mice who learned to associate the chamber with the shock will freeze in recognition of 138 the chamber. Lastly, we place the mice into a new chamber and replay the tone, where the 139 healthy mice will remember that the tone is associated with the shock and freeze in fear. We 140 found that Nud21 +/mice show abnormal behavior throughout the assay. Their initial fear 141 learning was attenuated: when exposed to the reinforcement sound cue played again two minutes 142 7 after the initial tone-shock pairing during training, they froze on average ~50% less often than 143 their wild-type littermates (Figure 2Ai) . Furthermore, the following day, they froze on average 144 ~30% less in both tests, indicating that Nud21 +/mice have reduced memory of the chamber or 145 the sound cue compared to their wild-type littermates (Figure 2Aii & iii) . 146
It is important to ensure that potential hyperactivity in the mutant mice does not confound 147 the conditioned fear test results. If the mice are hyperactive, they may freeze less in the 148 conditioned fear assay even if they remember the chamber or the cue. Therefore, we tested our 149
mice in the open field assay. We place the mice in an open chamber and record the distance they 150 travel in 30 minutes. We also record how much time they spend in the exposed center part of the 151 chamber compared to the more hidden periphery. In this assay, hyperactive mice cover a greater 152 distance, and anxious mice spend more time on the perimeter of the chamber (Crawley, 1985) . 153
We found that the Nud21 +/mice were not hyperactive, thus validating the conditioned fear 154 results by showing they are not confounded by hyperactivity and indicating that partial loss of 155 Nudt21 function does indeed cause cognitive defects (Figure 2Bi) . Intriguingly, the Nud21 +/-156 mice spent ~15% more time in the exposed, center part of the open field, which suggests they 157 have reduced anxiety and shows that they have neuropsychiatric features beyond learning and 158 memory deficits (Figure 2Bii) . 159
To determine if the learning deficits we detected in the Nud21 +/mice extended to other 160 learning paradigms, we tested spatial learning using the Morris water maze. In this assay, the 161 mice are trained over four days to locate a hidden platform in a pool of water using visual cues 162 provided on the perimeter of the room. We initially reveal the platform to the mice to confirm 163 visual acuity. Then the mice are individually placed at different locations around the perimeter of 164 the pool eight times per day and timed for how long it takes to locate the platform. Mice with 165 8 spatial learning deficits require more time to find the platform throughout training. For an 166 additional measurement, the platform is removed after the training and the mice are placed in a 167 novel location on the perimeter of the pool. We then record how much time, out of a minute, 168 they spend searching for the platform in the quadrant of the pool where it had been. Mice with 169 spatial learning and memory deficits spend relatively less time in the platform quadrant, 170 indicating that they do not remember its location as well. We found that the Nudt21 +/mice 171 indeed have spatial learning deficits. On average, they required more time to locate the platform 172 during their training trials, despite swimming slightly faster and covering a greater distance 173 (Figure 2Ci & ii) . Moreover, when the platform was removed, the Nudt21 +/mice spent ~30% 174 less time in the correct quadrant (Figure 2Ciii & iv) . Thus, the conditioned fear and Morris water 175 maze results show that Nudt21 +/mice have learning and memory deficits in multiple domains. 176 177 Nudt21 +/mice have increased cerebral spike activity. In addition to intellectual disability, the 178 patients with NUDT21-spanning deletions had seizures. In general, though, mice are much less 179 sensitive to seizure-causing mutations than humans, but seizure susceptibility can be assessed 180 using electroencephalography (EEG) (Amendola et al., 2014; Jiang et al., 1998; Kriscenski-Perry 181 et al., 2002; Miura et al., 2002) . Despite a lack of detectable seizures in Nudt21 +/mice, we found 182 significantly more EEG spikes in their frontal cortex relative to their wild-type littermates. This 183 result indicates that Nudt21 haploinsufficiency is alone sufficient to cause cortical 184 hyperexcitability, and suggests that NUDT21 loss of function might increase seizure risk ( Figure  185 3). 186 187 9 NUDT21 depletion induces aberrant alternative polyadenylation and altered protein levels. 188
The observations that individuals with NUDT21-spanning CNVs have intellectual disability (ID) 189 and that Nudt21 +/mice have learning deficits provides strong evidence that NUDT21 loss of 190 function causes disease, but do not reveal the molecular pathology. Therefore, to understand how 191 partial loss of NUDT21 function might sicken neurons and cause ID, we used shRNA to inhibit 192 NUDT21 in human embryonic stem cell (ESC)-derived glutamatergic neurons and assessed them 193 for proteome and alternative polyadenylation (APA) dysregulation. To assess the proteome, we 194 used mass spectrometry, and to directly measure APA events, we used poly(A)-ClickSeq (PAC-195 seq), an mRNA 3′-end sequencing method that allows for more accurate identification of 196 polyadenylation sites than standard RNA sequencing (Elrod et al., 2019; Routh et al., 2017) . The 197 genotypes cluster by principle component in both assays, showing that both approaches are 198 reproducible (Figure 4-figure supplement 1A & B) . 199
Like in the whole-brain extracts from Nudt21 +/mice, the human neurons had a 30% 200 reduction of CFIm25 protein, despite a greater reduction of NUDT21 mRNA (Figure 4A & B) . 201
This difference shows that there is also homeostatic stabilization of CFIm25 in human neurons. 202
Intriguingly, in addition to reduced NUDT21 mRNA levels as expected, the PAC-seq data also 203 showed that NUDT21 itself undergoes aberrant alternative polyadenylation following its 204 depletion (Figure 4Ci) . These shortened NUDT21 mRNAs have no stop codon, and are likely to 205 undergo non-stop decay, an mRNA decay mechanism that degrades mRNAs lacking an in-frame 206 stop codon (Frischmeyer et al., 2002; van Hoof et al., 2002) . 207
As in the NUDT21 CNV patient-derived lymphoblasts, NUDT21 loss of function causes 208 3′ UTR shortening of MECP2 in human neurons, as well as other genes strongly regulated by 209 NUDT21 in cancer-cell-line assays, such as VMA21, LAMC1, and PAK1 (Figure 4Cii & iii) 10 (Gennarino et al., 2015; Masamha et al., 2014) . Also, similar to other cell-line assays, NUDT21 211 loss of function causes widespread dysregulation of alternative polyadenylation, predominantly 212 resulting in mRNA shortening (Figure 4Ci -v & D) (Brumbaugh et al., 2018; Gruber et al., 2012; 213 Masamha et al., 2014) . Of the misregulated genes, 230 have a gnomAD probability of loss-of-214 function intolerance over 0.9, 43 cause intellectual disability when mutated, and of those, 18 are 215 autosomal or X-linked dominant (Supplemental data 1) (Lek et al., 2016; OMIM, 2019; Vissers 216 et al., 2015) . In addition to MECP2, misregulation of some of these genes is likely contributing 217 to pathogenesis. 218
Notwithstanding disrupted RNA localization, the most apparent consequence of 219 misregulated APA is altered protein levels (Tian and Manley, 2016). As expected, for many of 220 the genes with significantly misregulated APA, we also see concordant changes in protein levels 221 ( Figure 4E) . Most commonly, NUDT21 loss results in shorter mRNAs and increased protein, 222 such as with MeCP2 and VMA21, which respectively had protein-level increases of 50% and 223 almost 300% (Figure 4Cii- iii & E). However, there are exceptions that further clarify the 224 relationship between NUDT21 loss and protein levels. Occasionally, the shortened mRNA will 225 lose its stop codon and so likely undergo non-stop decay, resulting in reduced protein, such as 226 with ZCCHC6 (Figure 4Civ & E) . Conversely, as with KIF9, NUDT21 reduction occasionally 227 induces synthesis of longer mRNAs, and this could paradoxically increase protein levels if the 228 longer mRNAs gain a stop codon and cease to be degraded by non-stop decay (Figure 4Cv & E) . 229 Intriguingly, the degradation of KIF9 and others through non-stop decay in the control neurons 230
shows an example of non-stop decay being used for normal gene regulation, rather than just as a 231 quality control mechanism. We observed that ~15% of the genes with altered APA have a 232 change in the percentage of mRNA isoforms undergoing non-stop decay. However, the majority 233 11 follow the trends seen in cancer cell lines: NUDT21 loss of function in neurons causes 234 widespread 3′ UTR shortening and increased protein levels (Figure 4D & E) . 235
236

DISCUSSION 237
Here we show that a partial loss of Nudt21 function causes learning deficits and cortical 238 hyperexcitability in mice. Further, we show that partial loss of NUDT21 function broadly 239 disrupts gene expression in human neurons via widespread misregulated alternative 240 polyadenylation and protein levels. Alongside our previous discovery that patients with 241 NUDT21-spanning deletions have intellectual disability and gnomAD data that NUDT21 is a 242 highly constrained gene, our results provide strong evidence that partial loss of NUDT21 243 function causes intellectual disability (Gennarino et al., 2015; Lek et al., 2016) . 244
Because a relatively small reduction in CFIm25 protein was sufficient to cause deficits, 245 these data suggest that individuals with missense variants in NUDT21 that affect its function may 246 also have intellectual disability. Moreover, duplications of NUDT21, which we previously 247 showed are associated with ID, should lead to comparable dysregulation of alternative 248 polyadenylation and protein levels, including reduced MeCP2, and thus cause disease 249 (Gennarino et al., 2015) . 250
Beyond providing insight into NUDT21-associated disease, these data provide useful 251 perspectives on the broader field of pediatric neurodevelopmental disease research. They 252 illustrate the importance of protein-level homeostasis. A mere 30% reduction in CFIm25 protein 253 was sufficient to cause learning deficits in mice, and mice are neurologically less sensitive to 254 genetic insult than humans (Tan and Zoghbi, 2018). Further, many genes associated with 255 neurodevelopmental diseases encode proteins that regulate or affect transcription (Rubeis et al., 12 2014; Vissers et al., 2015; Yin and Schaaf, 2017) . NUDT21 provides another layer to this family 257 of genes insofar as it broadly affects alternative polyadenylation and protein levels. As a group, 258 these genes demonstrate how a partial loss or gain of function can result in large effects, and 259 further show that neurons are particularly sensitive to protein-level disequilibrium. 260
Lastly, while the observed 50% increase of MeCP2 protein likely contributes to the 261 symptoms seen in the NUDT21 CNV patients, the transcriptional dysregulation in neurons 262 following NUDT21 loss is so widespread that there are probably other CFIm25 targets that 263 mediate the patients' condition. Most likely, patient symptoms result from the additive effects of 264 numerous misregulated genes, including the dozens that are ID associated. This then points to 265 normalization of CFIm25 levels as the most viable molecular therapeutic strategy for treating 266 this disease. (Figure 4-figure supplement 1A) (E) Mass spectrometry 338 quantification of protein level fold change for genes with significantly altered APA (Padjusted 339 <0.1). For bar charts, error bars indicate SEM and data analyzed by unpaired, two-tailed t-test. 340 ***P<0.001. Principle component analysis shows sample clustering by treatment: (Figure 4-341   figure supplement 1B) . Source files for the PAC-seq and mass spectrometry quantification data 342 are available in We dissected then hemisected brains from three seven-week-old Nudt21 flox/flox C57BL/6J mice 376 and drop-fixed their brains in 4% PFA overnight with gentle rocking at 4°C. After fixation, we 377 cryoprotected the brains by gentle rocking in 30% sucrose solution in PBS at 4°C until the tissue 378 sank. We then froze the brains in OCT, cryosected 40µm sections, and stored them at 4°C. 379 380 For immunolabeling, we first blocked free-floating sections in 5% normal goat serum, 0.5% 381
Triton-X in PBS for one hour at room temperature. We then incubated the sections in CFIm25 382 23 primary antibody (1:50, Proteintech 10322-1-AP) in blocking buffer overnight at 4°C, followed 383 by three washes and Alexa Fluor 488 (1:1000, Molecular Probes) secondary antibody incubation 384 for two hours at room temperature. Lastly, we labeled the nuclei with DAPI (1:10,000) and 385 mounted the sections with Vectashield. We used a Leica TCS SP5 confocal microscope for 386 imaging and ImageJ Fiji for image processing. We confirmed the specificity of the CFIm25 387 antibody with siNUDT21 knockdown in HeLa cells. 388
389
RT-qPCR 390
RNA extraction: We dissected and hemisected the brains of five-week-old Nudt21 +/mice and 391 their wild-type littermates. We immediately flash froze them in liquid nitrogen and stored them 392 temporarily at -80°C. We later homogenized the half brains in TRIzol Reagent (ThermoFisher 393 Scientific) with the Polytron PT 10-35 GT (Kinematica). We then isolated the RNA by 394 chloroform phase separation, precipitated it with 2-propanol, and washed it with 75% ethanol. 395
We eluted the purified RNA in water. 396
397
We extracted RNA from shRNA-infected, human ESC-derived neurons in a 12-well plate: 4 398 wells non-silencing scrambled (RHS4348) and 8 wells shNUDT21 (V2LHS_253272 and 399 V2LHS_197948) (Dharmacon). We lysed the neurons in the tissue-culture plate with TRIzol 400 Reagent (ThermoFisher Scientific) and immediately transferred the lysate to microfuge tubes for 401 trituration. We then isolated the RNA by chloroform phase separation, precipitation with 2-402 propanol, washing with 75% ethanol, and eluting in water as with the mice. 
Western blot 435
Protein extraction: For the mice, we dissected and hemisected the brains of five-week-old 436 Nudt21 +/mice and their wild-type littermates. We immediately flash froze them in liquid 437 nitrogen and stored them temporarily at -80°C. We later homogenized the half brains with the 438 Polytron PT 10-35 GT (Kinematica) in lysis buffer: 2% SDS in 100 mM Tris-HCl, pH 8.5, with 439 protease and phosphatase inhibitors (ThermoFisher Scientific) and universal nuclease (Pierce). 440
We incubated the lysates on ice for ten minutes, then rotated them for 20 minutes at room 441 temperature. We spun the samples at top speed for 20 minutes to remove membrane, then 442 quantified the protein levels with the Pierce Protein BCA Assay kit (ThermoFisher Scientific). 443
For the ESC-derived neurons infected with shRNA targeting NUDT21, our extraction protocol 444 was similar, except we lysed them directly in their 12-well plate and rocked them for 20 minutes 445 at room temperature. 446
447
Western blot: We diluted the protein to 1 µg/µL in reducing buffer (LDS and sample reducing 448 agent (ThermoFisher Scientific)) and ran 10 µg/sample. We imaged the membranes with the LI-449 COR Odyssey and analyzed the data with LI-COR Image Studio (LI-COR Biosciences), 450 26 comparing H3-normalized CFIm25 levels. We confirmed the specificity of the CFIm25 antibody 451 by shNUDT21 knockdown in HEK293T cells. We present the data from human neurons infected 452 with shRNA clone V2LHS_253272 because we used it for the PAC-seq experiment. We to standard chow and water. We weighed a cohort of mice weekly from 4-12 weeks and a 465 different cohort at 30 weeks. We tested both male and females in all experiments and only 466 present the weight data separately because we never otherwise detected a difference between 467 them. We were blinded to the mice's genotype during all handling. 468
469
Genotyping 470
We determined the mice's genotypes by PCR amplification of tail lysates. 471 
Behavioral tests 482
Because neurodevelopmental disease loss-of-function mouse models typically have more 483 pronounced phenotypes when they are older, we started our behavioral battery on 30-week-old 484 mice. We performed the assays on two cohorts. We tested the mice during their light cycle, 485 typically between 11 AM and 5 PM. Prior to each assay, we habituated the mice to the testing 486 facility for 30-60 minutes. The investigators were blind to the mice's genotypes during all 487 assays. 488 489
Conditioned fear 490
We first habituate the mice for 30 minutes in an adjacent room on each day of the test. On day 491 one, we conditioned the mice by placing them in the habitest operant cage (Coulbourn) for a 492 training session. The training consists of two minutes habituation, then a 30 second 85 dB tone 493 followed by a foot shock of 1.0 mA for two seconds. After another two minutes, the 30 second 494 85 dB tone is played again (the training day cue). Throughout the experiment, except for the two 495 seconds during the foot shock, the FreezeFrame3 system (Coulbourn/Actimetrics) recorded the 496 28 mice's movement and freezing episodes. On day two, we performed the contextual and cued fear 497 assays. For contextual fear, we returned the mice to the test chambers precisely as we had done 498 during the training, and recorded their freezing in the chamber for five minutes. We waited two 499 hours before beginning the cued fear assay. We first changed the holding cages and test chamber 500 shape, color, texture, scent, and lighting to make the experience as unrecognizable as possible to 501 the mice. We then placed them in the modified chamber, and after three minutes played the 30 502 second 85 dB tone, then recorded their freezing for the following three minutes. We analyzed the 503 difference in freezing between the two groups after the second sound cue (training cue) on day 504 one, throughout the contextual fear test, and after the sound cue in the cued fear test, each by 505 unpaired, two-tailed t-test. We excluded data for all the mice from one contextual fear trial. We 506 suspect there was a technical error in the collection of those data: the FreezeFrame3 system 507 recorded them as freezing far more than the mice in any other trial (50-80%) and two of the three 508 were significant outliers in the Grubbs test. 509 510
Open field 511
We lit the room to 200 lux and set the ambient white noise to 60 dB during habituation and 512 throughout the test. We placed each mouse in the open field, a 40 x 40 x 30 cm chamber 513 equipped with photobeams (Accuscan Instruments), and recorded their activity for 30 minutes. 514
We analyzed total distance and center tolerance (center distance/total distance) by unpaired, two-515 tailed t-test. 516 517 Morris water maze 518 29 Our Morris water maze experiment took pl ace in a 120 cm diameter pool of water. We hid a 10 519 cm X 10 cm platform 0.5-1 cm underwater in the Southeast quadrant. On each wall of the testing 520 room, we taped brightly colored shapes that the mice can use for orientation. Our experiment 521 spanned four days. Each day, we set the lighting to 60 lux and habituated the mice in the testing 522 room in their home cages for 30 minutes, then ten minutes in holding cages. Prior to the first 523 day's experiment, we introduced the mice to the invisible platform by placing them on it for ten 524 seconds. We next pulled the mice into the water and let them swim for ten seconds to ensure they 525 could swim, then placed them directly in front of the platform to confirm they could climb back 526 on to it. We tested the mice in two training blocks per day for the four days. Each training block 527 consisted of four trials. For each trial, we placed the mice in a different quadrant of the pool 528 (North, South, East, or West); the quadrant order was the same for every mouse in the trial, but 529 different for every trial. We removed the mice after they found the platform, or if they did not 530 find that platform, we guided them to the platform to rest on it for ten seconds before removing 531 them. We used an EthoVision XT automated video tracking system (Noldus Information 532 Technology) to track the mice's location, speed, and latency to find the platform. After the 533 second training block on the fourth day, we immediately performed the probe trial: we removed 534 the platform and placed the mice in a new location, the Northwest quadrant, and tracked them for 535 60 seconds. We analyzed their speed by unpaired, two-tailed t-test; their latency to find the 536 platform by two-way, repeated measures ANOVA (genotype*block); and their time in each 537 quadrant in the probe trial by two-way, repeated-measures ANOVA (genotype*quadrant). 538 539 Animal behavior statistical analysis 540 30 From previous experience, we know a sample size of 14 animals is sufficient to detect 541 meaningful phenotypic differences in a neurobehavioral battery (Chao et al., 2010; Lu et al., 542 2017; Samaco et al., 2012) . We analyzed all the data with Prism 7 (Graphpad), following 543
Graphpad's recommendations. We used unpaired, two-tailed t-tests for all simple comparisons, 544 and two-way repeated measures ANOVAs for all two-factor comparisons. We present all data as 545 mean ± SEM. *, **, ***, and **** denote P<0.05, P<0.01, P<0.001, P<0.0001. 546 547
Video electroencephalography (EEG) and spike counting 548
Surgery and data recordings: The Baylor College of Medicine Institutional Animal Care and 549
Use Committee approved all research and animal care procedures. We tested eight Nudt21 +/-550 mice and six wild-type littermate controls. Experimenters were blind to the mouse genotype. We 551 secured 54-week-old mice on a stereotaxic frame (David Kopf) under 1-2% isoflurane 552 anesthesia. Each mouse was prepared under aseptic condition for the following recordings: the 553 cortical EEG recording electrodes of Channels 1 and 2 were made of Teflon-coated silver wires 554 (bare diameter 127 µm, A-M systems) and implanted in the subdural space of the parietal cortex 555 and frontal cortex, respectively, with reference at the midline over the cerebellum. The electrode 556 of the third channel, made of Teflon-coated tungsten wire (bare diameter 50 µm, A-M systems) 557 was stereotaxically aimed at the hippocampal dentate gyrus (1.9 mm posterior, 1.7 mm lateral, 558 and 1.8 mm below the bregma) with reference in the ipsilateral corpus callosum (Paxinos and 559 Franklin, 2001) . In addition, Teflon-coated silver wires were used to record the electromyogram 560 (EMG) in the neck muscles to monitor mouse activity. All of the electrode wires together with 561 the attached miniature connector sockets were fixed on the skull by dental cement. After two 562 weeks of post-surgical recovery, mice received three two-hour sessions of EEG/EMG recordings 563 31 over a week. Signals were amplified (100x) and filtered (bandpass, 0.1 Hz -1 kHz) with the 564 1700 Differential AC Amplifier (A-M Systems), then digitized at two kHz and stored on disk for 565 off-line analysis (DigiData 1440A and pClamp10, Molecular Devices). The time-locked mouse 566 behavior was recorded by ANY-maze tracking system (Stoelting Co.) . 567 568 EEG data analysis: Abnormal synchronous discharges were manually identified when the sharp 569 positive deflections exceeding twice the baseline and lasting 25-100 ms (Roberson et al., 2011). 570 We counted the number of abnormal spikes over the recording period using Clampfit 10 software 571 (Molecular Devices, LLC) and averaged the spike numbers across sessions for each animal. 572
Since the data follow a lognormal distribution, we statistically compared the genotypes with the 573 Mann-Whitney test using Prism 7 (Graphpad). The measure of central tendency is the geometric 574 mean and * indicates P<0.05. 575 576 shRNA lentivirus production and titer assessment 577
Virus production. We made several viruses that express shRNAs targeting NUDT21. We 578 transfected 45 ug DNA into 80%-90% confluent, low-passage HEK293T cells (ATCC CRL-579 3216; RRID:CVCL_0063) in 150 mm dishes at a 4:3:1 ratio of pGIPz, psPAX2, pMD2.G with 580
TransIT-293 transfection reagent (Mirus, MIR 2706). The following day, we changed the media 581 to 10 mL. At 48 and 72 hours, we collected and pooled their media, then centrifuged at 4000 x g 582 for ten minutes and filtered the supernatant through a Poly-ethersulfone filter (VWR, 28145-505) 583 to remove cellular debris. We concentrated the virus 100-fold with Lenti-X concentrator 584 (Clontech, 631231) following the manufacturer's recommendations before aliquoting and 585 freezing at -80C. 586 32 587 Titer assessment. 588
We measured the viral titer using Open Biosystems pGIPZ method (Thermo Fisher Scientific). 589
We plated 5 X 10 4 HEK293T cells in a 24-well plate. The following day, we made a serial 590 dilution of the virus in a 96-well plate, and when the HEK293T cells reached ~50% confluency, 591 we infected them with the diluted virus. We cultured the cells for two days, then counted the 592 tGFP colonies with Axiovert 25 microscope (Zeiss) microscope X-cite 120 lamp (ExFo) to 593 determine the viral titer. Our viruses had 10 9 transducing units/mL. 594
595
Confirmation 596
Compared to non-silencing scrambled control virus (RHS4348, Dharmacon), we confirmed 597 NUDT21 knockdown efficacy in HEK293T cells (ATCC CRL-3216; RRID:CVCL_0063), and 598 selected the two most efficient shRNAs for our studies: V2LHS_197948 and V2LHS_253272 599 (Dharmacon). 600 601 Human embryonic stem cell (hESC)-derived neuron culture 602
We used WA09 (H9; RRID:CVCL_9773) female embryonic stem cells (ESCs) to generate 603 human neurons as previously described (Jiang et al., 2019) . We differentiated neural progenitors 604 into human neurons over three weeks, changing the media every 3 d. Afterwards, we passaged 605 the neurons with trypsin. Three days after passaging, we infected the neurons with lentiviruses 606 containing pGIPZ shRNA clones at a multiplicity of infection of 10. We verified the tropism and 607 infectivity of the virus using the tGFP reporter signal. At day 3 after infection, we treated the 608 neurons with puromycin (0.75-1.25 g/ml) for 6 days to select for infected cells. We cultured the 609 33 cells for 60 days after infection, changing the media three times per week. We then aspirated all 610 the media and washed the cells with PBS before freezing them at -80C for later RNA and protein 611 extraction. 612 613 Poly(A) click-seq 614
RNA extraction 615
We extracted RNA from shRNA-infected, human ESC-derived neurons in a 12-well plate: 4 616 wells non-silencing scrambled (RHS4348) and 8 wells shNUDT21 (V2LHS_253272 and 617 V2LHS_197948) (Dharmacon). We know from past experience that we need at least three 618 samples for RNA-and PAC-seq analysis (Elrod et al., 2019; Maio et al., 2018; Routh et al., 619 2017; Tan et al., 2016) . We prepared four samples per genotype to allow for loss of one sample. 620
We lysed the neurons in the tissue-culture plate with TRIzol Reagent (ThermoFisher Scientific) 621 and immediately transferred the lysate to microfuge tubes for trituration. We then isolated the 622 RNA by chloroform phase separation, precipitation with 2-propanol, washing with 75% ethanol, 623 and eluting in water. 624 625
Library preparation and sequencing 626
We prepared sequencing libraries as previously described (Routh et al., 2017) . We reverse 627 transcribed 1 ug of total RNA with the partial P7 adapter (Illumina_4N_21T) and dNTPs with 628 the addition of spiked-in azido-nucleotides (AzVTPs) at 5:1. We click-ligated the p5 adapter 629 (IDT) to the 5′ end of the cDNA with CuAAC. We then amplified the cDNA for 21 cycles with 630 Universal primer and 3′ indexing primer and purified it on a 2% agarose gel by extracting 631 gene in both the control and NUDT21 knockdown conditions. We considered genes with mean 701 read counts <5 in either condition not expressed and so excluded them. 702 703 Because about half of genes that undergo APA have greater than two p(A) sites, we wanted to 704 use a statistic that could account for changes in all of the p(A) sites (Derti et al., 2012) . Thus, we 705 identified changes in alternative polyadenylation site usage using the Dirichlet multinomial test 706 in the DRIMSeq package, and computed adjusted p-values as previously described (Nowicka 707 and Robinson, 2016; Zhao et al., 2013) . We quantified the magnitude and direction of change in 708 polyadenylation site usage as an mRNA lengthening score. We summed the weighted read 709 counts per million (cpm) from each p(A) site in a gene to get that gene's mRNA length score. 710
We assigned the weights in decreasing order from the most distal p(A) site as below: 711
where Wi is the weight of i th distal polyadenylation site of a gene and NS is the of total number of 713 polyadenylation sites mapped to it. Thus, in a gene with 3 p(A) sites, the cpm at the most 714 promoter-distal site would all be counted (weight of 1) in the length score, the cpm at the 715 intermediate site would be weighted by 0.5, and the cpm at the proximal site would not be 716 counted (weight of 0). We then averaged the scores across samples and took the difference of 717 treated to controls for the relative mRNA length change. 718 719
Disease association determination 720
For the probability of loss of function intolerance (pLI) of all the genes, we used gnomAD (Lek 721 et al., 2016) . In addition, we cross-referenced the misregulated genes with published genetic 722 studies to see which were known to cause intellectual disability when mutated, then looked to the 723 38 Online Mendelian Inheritance in Man (OMIM) database to see if the pathological variants were 724 dominant or recessive (OMIM, 2019; Vissers et al., 2015) . 725 726
Mass spectrometry 727
We processed, measured, and analyzed the sample as previously described (Saltzman et al., 728 2018) . We summarize the main steps below. 729 730
Lysis and Digestion 731
We pelleted and lysed the shRNA-infected human neurons with three freeze (LN2) and thaw 732 (42ºC) cycles in 50 μL of ammonium bicarbonate + 1mM CaCl2. We then boiled the lysate at 733 95°C for two minutes with vortexing at 20 second intervals, and then centrifugation at 21,000 rcf. 734
We digested 50 μg of total protein with a 1:20 solution of 1 μg/μL trypsin:protein overnight at 735 37°C with shaking and then again with a 1:100 solution of 1 μg/μL trypsin:protein for 4 hours. 736
We extracted the peptides with 80% acetonitrile + 0.1% formic acid solution, followed by 737 centrifugation at 10,000 g, and vacuum drying. 738 739
Off-Line Basic pH Reverse Phase Peptide Fractionation 740
A "15F5R" protocol was used for off-line fractionation as described before (Saltzman et al., 2018) . 741
We filled a 200 μl pipette tip with 6 mg of C18 matrix (Reprosil-Pur Basic C18, 3 μm, Dr. 742
Maisch GmbH) on top of a C18 disk plug (EmporeTM C18, 3M). We dissolved 50 μg of 743 vacuum-dried peptides with 150 μl of pH10 ABC buffer and loaded it onto the pre-equilibrated 744 C18 tip. We eluted bound peptides with fifteen 2%-step 2-30% gradient of ACN non-745 contiguously combined into five pools, and then vacuum dried. 746 39 747
Mass Spectrometry 748
We analyzed fractionated peptides on an Orbitrap Fusion mass spectrometer coupled with the 749 Nanospray Flex ion sources and an UltiMate 3000 UPHLC (Thermo Fisher Scientific). For each 750 run, we loaded approximately one microgram of peptide onto a two cm 100 μm ID pre-column 751 and resolved it on a twelve cm 100 μm ID column, both packed with sub-twi μm C18 beads 752 (Reprosil-Pur Basic C18, Catalog #r119.b9.0003, Dr. Maisch GmbH). We maintained a constant 753 flow rate for 100-minute 2-28% B gradient elutions, where A is water and B is 90% acetonitrile, 754 both with 0.1% formic acid. Module (Käll et al., 2007; Perkins et al., 1999) . We matched MS1 precursors in a 350-10,000 761 mass range against the tryptic RefProtDB database digest (2015-06-10 download) with Mascot 762 permitting up to 2 missed cleavage sites (without cleavage before P), a precursor mass tolerance 763 of 20 ppm, and a fragment mass tolerance of 0.5 Da. We allowed the following dynamic 764 modifications: Acetyl (Protein N-term), Oxidation (M), Carbamidomethyl (C), DeStreak (C), and 765 Deamidated (NQ). For the Percolator module, we set the target strict and relaxed FDRs for PSMs 766 at 0.01 and 0.05 (1% and 5%), respectively. We used gpGrouper (v1.0.040) for gene product 767 inference and label-free iBAQ quantification with shared peptide distribution. 768 769
